In the fast-paced world of medical research, where hope is often measured in small, incremental data points, the detailed reports emerging from clinical trials offer crucial intelligence for the entire scientific community

Parkinson’s Disease (PD) is perhaps the most well-known motor neurodegenerative disorder, relentlessly affecting movement and quality of life. Globally, it impacts approximately 1% of individuals aged over 60 years, making it the most common condition of its type